Early Neuroaxonal Damage in Neurologic Disorders Associated With GAD65 Antibodies

Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis

(2023) Juliette Brenner et al.   NEUROLOGY

Antibodies Against Glutamic Acid Decarboxylase 65 Are Locally Produced in the CSF and Arise During Affinity Maturation

(2023) Michelle Biljecki et al.   Neurology-Neuroimmunology & Neuroinflammation

Mesiotemporal Volumetry, Cortical Thickness, and Neuropsychological Deficits in the Long-term Course of Limbic Encephalitis

(2023) Antonia Harms et al.   Neurology-Neuroimmunology & Neuroinflammation

Temporal lobe epilepsy with GAD antibodies: neurons killed by T cells not by complement membrane attack complex

(2022) Anna R Tröscher et al.   BRAIN

CerebNet: A fast and reliable deep-learning pipeline for detailed cerebellum sub-segmentation

(2022) Jennifer Faber et al.   NEUROIMAGE

Clinical spectrum of high-titre GAD65 antibodies

(2021) Adrian Budhram et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3

(2021) Jennifer Faber et al.   MOVEMENT DISORDERS

Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis

(2021) Gregory S. Day et al.   NEUROLOGY

Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis

(2021) Franziska S. Thaler et al.   Neurology-Neuroimmunology & Neuroinflammation

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

(2019) Jens Kuhle et al.   NEUROLOGY

Fluid biomarkers for mild traumatic brain injury and related conditions

(2016) Henrik Zetterberg et al.   Nature Reviews Neurology

Cerebellar Ataxia and Glutamic Acid Decarboxylase Antibodies

(2014) Helena Ariño et al.   JAMA Neurology